Cleared Traditional

K883914 - FATIGMETER

K883914 is an FDA 510(k) clearance for FATIGMETER, manufactured by K. Jimbo Co., Inc.. The device is a Class 2 Neurology device with product code GWE cleared through the Traditional 510(k) pathway after a 410-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1989
Decision
410d
Days
Class 2
Risk

K883914 is an FDA 510(k) clearance for the FATIGMETER. Classified as Stimulator, Photic, Evoked Response (product code GWE), Class II - Special Controls.

Submitted by K. Jimbo Co., Inc. (Los Angeles, US). The FDA issued a Cleared decision on October 31, 1989 after a review of 410 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K883914

510(k) Number K883914 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1988
Decision Date October 31, 1989
Days to Decision 410 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
261d slower than avg
Panel avg: 149d · This submission: 410d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWE Device Classification - Class 2, Special Controls

Product Code GWE Stimulator, Photic, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWE Stimulator, Photic, Evoked Response

All 48
Devices cleared under the same product code (GWE) and FDA review panel - the closest regulatory comparables to K883914.
KILOWIN
K971214 · Cadwell Laboratories, Inc. · Jun 1998
TOMEY PE-400 PORTABLE ERG & VEP WITH OPTIONAL PS-4
K932571 · Tomey Corporation USA · Aug 1995
ADVANTAGE EP
K903734 · Clark Davis Medical Systems, Inc. · Jul 1991
TECA/MEDELEC MISTRAL
K880593 · Teca, Inc. · Apr 1988
PHOTIC STIMULATOR MODELS 580-PSCOMP,PSCEEG,PSSTAL
K874136 · Bio-Logic Systems Corp. · Mar 1988
MODEL 100 VISUAL EVOKED RESPONSE RECORDING SYSTEM
K872725 · Eyetronics, Inc. · Aug 1987